Publication | Open Access

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

InflammationImmunologyGastroenterologyPathologyPlacebo-controlled TrialInflammatory Rheumatic DiseaseImmune-mediated Inflammatory DiseasesUlcerative ColitisMedicineInflammatory DiseaseHumanized Monoclonal AntibodyDigestive System Diseases